Edwards Lifesciences | EW - Operating Profit

Stock Price
84.15
Daily Change
4.43 5.56%
Monthly
1.79%
Yearly
10.67%
Q2 Forecast
82.35

Edwards Lifesciences reported $514.7M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 2.49M 2.28M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Globus Medical USD 181.31M 298.83M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
Intuitive Surgical USD 859.7M 5.6M Mar/2026
J&J USD 6.62B 1.03B Mar/2026
Masimo USD 83.9M 300K Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025